Key result
Concurrent pericardial effusion in RCHF links to significantly shorter survival, with median survival of ~7 days.
Why the study?
The study aimed to describe and compare clinical characteristics and survival among dogs with pulmonary hypertension-associated right-sided congestive heart failure according to cavitary effusion pattern.
Does the cavitary effusion pattern (concurrent pericardial or pleural effusion vs ascites alone) affect survival time in dogs with pulmonary hypertension-associated right-sided congestive heart failure?
Cohort (n=61)
Yes
Does the cavitary effusion pattern (concurrent pericardial or pleural effusion vs ascites alone) affect survival time in dogs with pulmonary hypertension-associated right-sided congestive heart failure?
In dogs with pulmonary hypertension-associated right-sided congestive heart failure, concurrent pericardial effusion was associated with markedly shorter median survival (7 days vs 157 days for ascites alone), though larger studies are needed to confirm this finding.
Answers are grounded in this paper and cite their sources.
Should not yet change effusion management in canine RCHF; leaves open independent prognostic value of pericardial effusion pending larger studies.
Objective To describe and compare clinical characteristics and survival among dogs with pulmonary hypertension–associated right-sided congestive heart failure (RCHF) according to cavitary effusion pattern. Methods This retrospective multicenter observational study included client-owned dogs with pulmonary hypertension–associated RCHF presented to 3 referral hospitals from February 2021 through April 2025. Pulmonary hypertension was assessed echocardiographically, and RCHF was defined by ascites with caudal vena cava dilation. Dogs were categorized as having ascites alone, ascites with pleural effusion, or ascites with pericardial effusion. Clinical and imaging characteristics were compared among groups, and survival was evaluated using Kaplan-Meier and exploratory Cox regression analyses. Results 61 dogs were included: 40 with ascites alone, 16 with pleural effusion, and 5 with pericardial effusion. Median survival was 157, 42.5, and 7 days, respectively. In an exploratory multivariable Cox model adjusted for age and grouped etiology, pericardial effusion was associated with a higher mortality hazard compared with ascites alone. Pleural effusion was not significantly associated with mortality. Conclusions Survival differed according to cavitary effusion pattern in this retrospective cohort of dogs with RCHF. Dogs with concurrent pericardial effusion had the shortest observed survival and a higher adjusted mortality hazard, although this finding should be interpreted cautiously because only 5 dogs had pericardial effusion. Clinical Relevance Cavitary effusion pattern may provide additional descriptive information when assessing dogs with RCHF. Concurrent pericardial effusion may identify a subgroup with shorter observed survival, but its prognostic value requires confirmation in larger cohorts.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2026) conducted a cohort in Pulmonary hypertension-associated right-sided congestive heart failure in dogs (n=61). Ascites with pericardial effusion or pleural effusion vs. Ascites alone was evaluated on Survival time / all-cause mortality. Concurrent pericardial effusion in dogs with RCHF was associated with shorter median survival than pleural effusion or ascites alone and a higher mortality hazard.
Synapse has enriched 10 related papers. Consider them for comparative context: